Nanotechnology in cosmetics and sunscreens: An update

Journal of Drugs in Dermatology

Volumn 8, Issue 10, 2009, Pages 955-958

  Zippin, Jonathan Hale ^a   Friedman, Adam ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; LIPOSOME; NANOMATERIAL; NANOPARTICLE; SUNSCREEN; SURFACTANT;

COSMETIC INDUSTRY; CYTOTOXICITY; FOOD AND DRUG ADMINISTRATION; GENOTOXICITY; HUMAN; HYDROPHILICITY; LIPOPHILICITY; MAMMAL CELL; NANOEMULSION; NANOTECHNOLOGY; PARTICLE SIZE; REVIEW; RISK ASSESSMENT; METHODOLOGY; NOTE;

COSMETICS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; SUNSCREENING AGENTS;

EID: 70350708308     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Heize T. Nanoscience and nanotechnology in Europe: Analysis of publications and patent applications including comparisons with the United States. Nanotechnol Law Bus. 2004;1(4):10.
2. Katz L. Nanotechnology and applications in cosmetics. A.C.S. symposium series. 2007;961:193-200.
3. Borm PJ, Robbins D, Haubold S, et al. The potential risks of nanomaterials: A review carried out for ECETOC. Part Fibre Toxicol. 2006;3:11.
4. Council ASaC. A Review of the Potential Occupational Health & Safety Implications of Nanotechnology. ISBN. 2006;0642:32609.
5. Davies J. Oversight of Next Generation Nanotechnology. Woodrow Wilson Institute for Scholars. 2009; Available at www.wilsoncenter.org/nano.
6. Chan VS. Nanomedicine: An unresolved regulatory issue. Regul Toxicol Pharmacol. 2006;46(3):218-224. (Pubitemid 44692901)
7. Oberdorster E. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005;113(7):823-829.
8. Drexler K. Machine-Phase Nanotechnology. Sci Am. 2001;285(3):74-75.
9. Drexler K. Nanosystems: Molecular Machinery, Manufacturing, and Computation. New York, NY: John Wiley and Sons; 1992.
10. Nasir A. NanoPresent and NanoFuture: The growing role of shrinking technology in dermatology. Cosmetic Dermatology. 2009;22(4):194-200.
11. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622-627. (Pubitemid 43191298)
12. Shaefer H, Lademann J. The role of follicular penetration. A differential view. Skin Pharm and Appl Skin Physio. 2001;14Suppl1:23-27. (Pubitemid 34299160)
13. Chang E, Thekkek N, Yu WW, et al. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small. 2006;2(12):1412-1417. (Pubitemid 44786881)
14. Derfus AM CW, and Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 2004;4:11-18. (Pubitemid 38167855)
15. Kraeling M. Evaluation of in vitro penetration of quantum dot nanoparticles into human skin. Toxocologist. 2007;96:196.
16. Leroueil PR, Berry SA, Duthie K, et al. Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett. 2008;8(2):420-424. (Pubitemid 351345993)
17. Mortensen L, Oberdorster G, Pentland AP, Delouise LA. In vivo skin penetration of quantum dot nanoparticles in the murine model: The effect of UVR. Nano Lett. 2008;8(9):2779-2787.
18. Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol. 2008;228(2):200-211.
19. Deutsch C. Cosmetics Break the Skin Barrier. New York Times. January 8, 2005.
20. Chen H, Roco MC, Li X, Lin Y. Trends in nanotechnology patents. Nat Nanotechnol. Mar 2008;3(3):123-125. (Pubitemid 351355142)
21. Matlack CaC, J. Nano Nano on the Wall. European Business Seection; Business Week. December 12, 2005.
22. Chen HaR, M. Mapping Nanotechnology Innovations and Knowledge: Global and Longitudinal Patent and Literature Analysis Series. Springer, U.S.; 2009.
23. Sonneville-Aubrun O, Simonnet JT, L'Alloret F. Nanoemulsions: A new vehicle for skincare products. Adv Colloid Interface Sci. 2004;108-109:145-149.
24. Junginger HE, Bouwstra JA. Liposomes and niosomes: Interactions with human skin. Cosmet Toiletries. 1991;106:45-50.
25. Lopez C. Focus on the supramolecular structure of milk fat in dairy products. Reprod Nutr Dev. 2005;45(4):497-511. (Pubitemid 41136571)
26. Maynard A. Nanotechnology: A Research Strategy for Addressing Risk. Project on Emerging Nanotechnologies. Washington: Woodrow Wilson International Center for Scholars; 2006.
27. Risks. ESCoEaNIH. Opinion on the Scientific Aspects of the Existing and Proposed Definitions Relating to Products of Nanoscience and Nanotechnologies. Brussels November 29 2007.
28. Gelis C, Girard S, Mavon A, et al. Assessment of the skin photoprotective capacities of an organo-mineral broad-spectrum sunblock on two ex vivo skin models. Photodermatol Photoimmunol Photomed. 2003;19(5):242-253. (Pubitemid 37121536)
29. Nohynek GJ, Schaefer H. Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol. 2001;33(3):285-299. (Pubitemid 32590816)
30. Project. WHOITGU. Protection against Exposure to Ultraviolet Radiation. 1998; http://www.who.org.
31. Tan MH, Commens CA, Burnett L, Snitch PJ. A pilot study on the percutaneous absorption of microfi ne titanium dioxide from sunscreens. Australas J Dermatol. 1996;37(4):185-187. (Pubitemid 126440414)
32. Dussert AS, Gooris E, Hemmerle J. Characterization of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int J Cosmet Sci. 1997;19(3):119-129. (Pubitemid 27303816)
33. Lademann J, Weigmann H, Rickmeyer C, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifi ce. Skin Pharmacol Appl Skin Physiol. 1999;12(5):247-256. (Pubitemid 29401452)
34. Gamer AO, Leibold E, van Ravenzwaay B. The in vitro absorption of microfi ne zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro. 2006;20(3):301-307. (Pubitemid 43343759)
35. Cross SE, Innes B, Roberts MS, et al. Human skin penetration of sunscreen nanoparticles: In-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol. 2007;20(3):148-154. (Pubitemid 46788286)
36. Mavon A, Miquel C, Lejeune O, et al. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol. 2007;20(1):10-20. (Pubitemid 46005806)
37. Lademann J, Otberg N, Richter H, et al. Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol. 2001;14 Suppl 1:17-22.
38. Rouse JG, Yang J, Ryman-Rasmussen JP, et al. Effects of mechanical fl exion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett. 2007;7(1):155-160. (Pubitemid 46225845)
39. Baroli B, Ennas MG, Loffredo F, et al. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol. 2007;127(7):1701-1712. (Pubitemid 46933398)
40. Gorog P, Pearson JD, Kakkar VV. Generation of reactive oxygen metabolites by phagocytosing endothelial cells. Atherosclerosis. 1988;72(1):19-27.
41. Yoshikawa S. Biological response to a foreign body. J Jpn Soc Biomater. 1991;9:94-103.
42. Nakagawa Y, Wakuri S, Sakamoto K, Tanaka N. The photogenotoxicity of titanium dioxide particles. Mutat Res. 1997;394(1-3):125-132.
43. SCCNFP. Opinion of the Scientifi c Committee on Cosmetic Products and Non-Food Products Intended for Consumers Concerning Titanium dioxide. Brussels, Belgium; October 24, 2000.
44. Serpone N, Salinaro A, Emeline A. Deleterious effects of sunscreen titanium dioxide nanopartciles on DNA. Proc. SPIE. 2001;4258:86-98.
45. Cai R, Hashimoto K, Ithon K, et al. Photo-killing of malignant cells with ultrafi ne TiO2 powder. Bull Chem Soc Jpn. 1991;64:1268-1273.